Hardy Reed’s Amedisys AMED Stock Holding History

Hardy Reed’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,672	Closed	-$288K	–	83
2022 Q1	$288K	Hold	1,672	–	–	0.05%	66
2021 Q4	$271K	Buy	+1,672	New	+$269K	0.04%	87
2021 Q3	–	Sell	-1,033	Closed	-$253K	–	104
2021 Q2	$253K	Hold	1,033	–	–	0.05%	89
2021 Q1	$274K	Buy	+1,033	New	+$291K	0.05%	83

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Hardy Reed's AMED Position: Q2 2022 in Review

Hardy Reed sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,672 shares — an estimated $288K sold.

Hardy Reed first reported a position in AMED in Q1 2021 and held it in 4 quarters. The position peaked at $288K in Q1 2022. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

Hardy Reed reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
Hardy Reed sold 1,672 Amedisys shares in Q2 2022, an estimated $288K.
Hardy Reed first reported a position in Amedisys in Q1 2021 and held it in 4 quarters.
Hardy Reed's Amedisys position peaked at $288K in Q1 2022.
289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Hardy Reed's 13F filing for Q2 2022, filed 28 Jul 2022.